Clinical Trials Directory

Trials / Unknown

UnknownNCT04513795

EARLY-MYO-SEPSIS Registry

EARLY-MYO-SEPSIS (EARLY Assessment of MYOcardial Injury in Sepsis Patient) Registry

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
85 Years
Healthy volunteers
Not accepted

Summary

The diagnosis and pathophysiology of sepsis-induced cardiac dysfunction remain unknown. This registry is to evaluate characteristics of sepsis patients by multi-modalities imaging, including echocardiography, cardiovascular magnetic resonance imaging in 300 patients in 5 sites. Subjects will be followed up to 2 years.

Detailed description

Approximately 20-30 million patients worldwide suffer from sepsis every year, which is increasing at the rate of 8% to 13% per year. It is possible that sepsis progress to multiple organ dysfunction in the early stage, with a fatality of 30% to 60%. Myocardium is one of the most vulnerable tissue under the abnormal 'inflammation storm'.Cardiac dysfunction is one of the important predictors for mortality of sepsis.Patients with myocardial depression have an apparently higher mortality rate (70%) as compared with septic patients without cardiac impairment (20%). Although several trials had explored the diagnosis and treatment of sepsis-induced cardiac dysfunction, the effective characteristic depict and effective therapy remain incompletely understand. This is a prospective, multi-center, non-randomized, observational registry study of sepsis patients that undergo multi-modality imaging.

Conditions

Timeline

Start date
2020-09-01
Primary completion
2022-08-31
Completion
2023-08-31
First posted
2020-08-14
Last updated
2020-08-14

Source: ClinicalTrials.gov record NCT04513795. Inclusion in this directory is not an endorsement.